Nkarta (NKTX) Assets Average (2020 - 2026)
Nkarta (NKTX) posted quarterly Assets Average of $388.1 million for Q1 2026, down 20.12% year-over-year from $485.9 million in Q1 2025, and down 6.63% quarter-over-quarter from $415.7 million in Q4 2025.
Nkarta (NKTX) Assets Average (2020 - 2026) Analysis & Trends
Nkarta's Assets Average history runs 7 years deep, the most recent figure standing at $388.1 million for Q1 2026.
- In Q1 2026, Assets Average fell 20.12% year-over-year to $388.1 million; the TTM figure through Mar 2026 stood at $388.1 million (down 20.12% YoY), while the FY2025 annual figure was $452.7 million, up 2.88% from the prior year.
- Assets Average for Q1 2026 stood at $388.1 million, down from $415.7 million in the prior quarter.
- The five-year high for Assets Average was $565.5 million in Q2 2024, with the low at $290.1 million in Q1 2022.
- The 5-year median for Assets Average is $459.5 million (2025), against an average of $452.7 million.
- The sharpest annual moves came in 2022 and 2026: Assets Average jumped 72.46% in 2022, then fell 20.12% in 2026.
- Nkarta's Assets Average stood at $488.4 million in 2022, then dropped by 19.66% to $392.4 million in 2023, then surged by 31.66% to $516.6 million in 2024, then fell by 19.53% to $415.7 million in 2025, then decreased by 6.63% to $388.1 million in 2026.
- Business Quant data shows NKTX's Assets Average at $388.1 million in Q1 2026, $415.7 million in Q4 2025, and $437.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 19.82 Bn |
| 10 | Nkarta | 197.04 Mn | 197.04 Mn | - | 354.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 354.86 Mn |
| Mar 31, 2026 | 388.14 Mn |
| Dec 31, 2025 | 415.72 Mn |
| Sep 30, 2025 | 437.77 Mn |
| Jun 30, 2025 | 459.46 Mn |
| Mar 31, 2025 | 485.91 Mn |
| Dec 31, 2024 | 516.62 Mn |
| Sep 30, 2024 | 543.06 Mn |
| Jun 30, 2024 | 565.51 Mn |
| Mar 31, 2024 | 477.91 Mn |
| Dec 31, 2023 | 392.37 Mn |
| Sep 30, 2023 | 417.45 Mn |
| Jun 30, 2023 | 443.60 Mn |
| Mar 31, 2023 | 465.55 Mn |
| Dec 31, 2022 | 488.37 Mn |
| Sep 30, 2022 | 503.72 Mn |
| Jun 30, 2022 | 404.97 Mn |
| Mar 31, 2022 | 290.10 Mn |
| Dec 31, 2021 | 283.18 Mn |
| Sep 30, 2021 | 300.79 Mn |